Published in Health Business Week, November 17th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Angiotech Pharmaceuticals.
Report 1: Angiotech Pharmaceuticals, Inc. (ANPI; TSX; ANP) announced positive preclinical data related to its Vascular Wrap paclitaxel-eluting mesh and Lifespan graft technology platform in hemodialysis patients.
Although synthetic grafts are currently used in approximately 40 percent of hemodialysis patients who require a permanent vascular access, primary patency rates remain poor. Most graft failures are caused by growth of scar tissue...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week